Recurrent Small Cell Lung Cancer (SCLC) Completed Phase 1 Trials for Lipoic acid (DB00166)

Also known as: Recurrent Small-cell Lung Cancer (SCLC) / Recurrent Small Cell Lung Cancer / Refractory Small cell lung cancer / Small Cell Lung Cancer Recurrent

IndicationStatusPhase
DBCOND0122754 (Recurrent Small Cell Lung Cancer (SCLC))Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01931787CPI-613 in Treating Patients With Relapsed or Refractory Small Cell Lung CancerTreatment